Nifty
:
11873.05
Sensex
:
40431.60
110.60 (0.94%)
448.62 (1.12%)
Nifty
Sensex
:
:
11873.05
40431.60
110.60 (0.94%)
448.62 (1.12%)

Chemicals

Rating :
76/99  (View)

BSE: 543213 | NSE: ROSSARI

NSE BSE
794.55
20.50 (2.65%)
19-Oct-2020 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  772.00
  •  807.70
  •  768.00
  •  774.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  291292
  •  2314.46
  •  859.00
  •  664.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,016.74
  • 61.30
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,956.43
  • 0.06%
  • 11.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.69%
  • 2.53%
  • 3.91%
  • FII
  • DII
  • Others
  • 4.07%
  • 13.39%
  • 3.41%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.30
  • 27.50
  • 27.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.20
  • 53.55
  • 18.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.09
  • 80.50
  • 31.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
109
0
0
0
0
0
0
0
0
0
0
0
Expenses
86
0
0
0
0
0
0
0
0
0
0
0
EBITDA
24
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
22%
0%
0%
0%
0%
0%
0%
0%
Other Income
2
0
0
0
0
0
0
0
0
0
0
0
Interest
1
0
0
0
0
0
0
0
0
0
0
0
Depreciation
4
0
0
0
0
0
0
0
0
0
0
0
PBT
20
0
0
0
0
0
0
0
0
0
0
0
Tax
5
0
0
0
0
0
0
0
0
0
0
0
PAT
15
0
0
0
0
0
0
0
0
0
0
0
PATM
14%
0%
0%
0%
0%
0%
0%
0%
EPS
2.91
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 16
Mar 15
Mar 14
Net Sales
-
600
516
292
179
171
155
Net Sales Growth
-
16%
77%
63%
4%
10%
 
Cost Of Goods Sold
-
372
338
197
131
123
108
Gross Profit
-
228
178
95
48
48
47
GP Margin
-
38%
34%
33%
27%
28%
30%
Total Expenditure
-
495
439
247
166
156
140
Power & Fuel Cost
-
2
1
1
1
1
1
% Of Sales
-
0%
0%
0%
0%
0%
0%
Employee Cost
-
37
27
20
12
11
11
% Of Sales
-
6%
5%
7%
6%
7%
7%
Manufacturing Exp.
-
27
5
2
3
3
3
% Of Sales
-
4%
1%
1%
2%
2%
2%
General & Admin Exp.
-
17
16
11
1
6
6
% Of Sales
-
3%
3%
4%
1%
3%
4%
Selling & Distn. Exp.
-
34
34
10
3
8
8
% Of Sales
-
6%
7%
3%
2%
4%
5%
Miscellaneous Exp.
-
7
17
7
16
4
4
% Of Sales
-
1%
3%
3%
9%
3%
2%
EBITDA
-
105
77
45
13
15
15
EBITDA Margin
-
17%
15%
15%
7%
9%
9%
Other Income
-
4
1
1
0
0
0
Interest
-
4
4
1
4
5
5
Depreciation
-
17
12
5
5
5
5
PBT
-
88
62
40
5
5
4
Tax
-
23
17
11
1
1
1
Tax Rate
-
26%
27%
27%
30%
21%
15%
PAT
-
65
45
29
3
4
4
PAT before Minority Interest
-
65
45
29
3
4
4
Minority Interest
-
0
0
0
0
0
0
PAT Margin
-
11%
9%
10%
2%
2%
2%
PAT Growth
-
44%
56%
756%
-9%
-2%
 
EPS
-
12.61
8.74
5.59
0.65
0.72
0.73

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
287
129
94
Share Capital
10
4
4
Total Reserves
276
125
90
Non-Current Liabilities
69
3
4
Secured Loans
34
1
1
Unsecured Loans
0
0
0
Long Term Provisions
35
1
0
Current Liabilities
169
119
68
Trade Payables
97
105
40
Other Current Liabilities
20
8
6
Short Term Borrowings
27
3
19
Short Term Provisions
24
3
3
Total Liabilities
525
251
166
Net Block
94
83
45
Gross Block
122
138
88
Accumulated Depreciation
29
55
43
Non Current Assets
178
90
60
Capital Work in Progress
22
3
10
Non Current Investment
4
0
3
Long Term Loans & Adv.
58
4
2
Other Non Current Assets
0
0
0
Current Assets
346
162
106
Current Investments
14
0
4
Inventories
58
55
35
Sundry Debtors
94
86
60
Cash & Bank
127
6
1
Other Current Assets
53
0
0
Short Term Loans & Adv.
52
14
5
Net Current Assets
178
43
38
Total Assets
525
251
166

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
55
69
24
PBT
88
62
40
Adjustment
18
14
6
Changes in Working Capital
-31
11
-11
Cash after chg. in Working capital
75
87
34
Interest Paid
0
0
0
Tax Paid
-20
-18
-11
Other Direct Exp. Paid
0
0
0
Extra & Other Items
0
0
0
Cash From Investing Activity
-190
-35
-20
Net Fixed Assets
-7
-43
Net Investments
-15
3
Others
-168
5
Cash from Financing Activity
157
-30
-5
Net Cash Inflow / Outflow
21
5
-2
Opening Cash & Equivalents
6
1
2
Closing Cash & Equivalent
29
6
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
56
293
214
114
107
101
ROA
16%
22%
20%
3%
3%
3%
ROE
32%
41%
36%
7%
8%
9%
ROCE
38%
53%
40%
10%
11%
11%
Fixed Asset Turnover
5.78
4.58
3.65
3.41
2.54
2.30
Receivable days
54
52
66
62
62
66
Inventory Days
34
32
36
58
78
99
Payable days
76
61
56
58
59
72
Cash Conversion Cycle
13
22
45
62
81
93
Total Debt/Equity
0.23
0.04
0.22
0.45
0.93
1.00
Interest Cover
26
18
30
2
2
2

Annual Reports:

Financial Year 2019
Financial Year 2018
Financial Year 2017
Financial Year 2016
Financial Year 2015
Financial Year 2014
Financial Year 2013
Financial Year 2012

News Update


  • Rossari Biotech reports 9% rise in Q1 consolidated net profit
    24th Aug 2020, 09:47 AM

    Total consolidated income of the company decreased by 13.62% at Rs 111.07 crore for Q1FY21

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.